tb/hiv: impact and opportunities helene gayle, md, mph bill and melinda gates foundation date, 2004
TRANSCRIPT
![Page 1: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/1.jpg)
TB/HIV: Impact and Opportunities
Helene Gayle, MD, MPHBill and Melinda Gates FoundationDATE, 2004
![Page 2: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/2.jpg)
Small and Fujiwara, N Eng J Med 343:189, 2001
The annual risk of TB in HIV infected
approximates the lifetime risk of HIV uninfected
HIV/TB: Profound Effect on Individuals
![Page 3: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/3.jpg)
HIV/TB: Profound Effect on Populations
Kenyon et al., Int J TB Lung Dis 1999;3:4-11
![Page 4: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/4.jpg)
HIV/TB: Profound Effect on Populations
0
100
200
300
400
500
600
700
800
88 89 90 91 92 93 94 95 96 97 98 99 '00 '01Year
Rat
e pe
r 100
,000
South Africa Kenya Swaziland Malawi
Zambia Namibia Botswana
WHO TB Surveillance Report, 2003
![Page 5: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/5.jpg)
TB/HIV Co-Authorship Network
Medline 97-01Medline 97-01 TB 12,352TB 12,352 HIV 43,455HIV 43,455““Top” 50 authorsTop” 50 authors
Separate Responses
Abernethy and Small, unpublished
![Page 6: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/6.jpg)
A Coordinated Response
C R E A ETo design, implement and evaluate a portfolio of community level trials of new strategies to reduce tuberculosis incidence in populations with high rates of HIV and TB co-infection.
![Page 7: TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004](https://reader036.vdocuments.site/reader036/viewer/2022081515/56649cef5503460f949bd8ac/html5/thumbnails/7.jpg)
TB/HIV Ultimate Need for New Tools
FIND/TDR for diagnostics ($30M)
Global Alliance for new drug ($25 M)
Aeras for vaccines ($83M)
Reaping the benefitsReaping the benefitsof science of science